Drug Profile
Epinephrine oral film - Aquestive Therapeutics
Alternative Names: Anaphylm; AQST-109; Epinephrine - Aquestive Therapeutics; Epinephrine SSF - Aquestive Therapeutics; Epinephrine sublingual film - Aquestive Therapeutics; Epinephrine sublingual soluble film - Aquestive TherapeuticsLatest Information Update: 19 Mar 2024
Price :
$50
*
At a glance
- Originator MonoSol Rx
- Developer Aquestive Therapeutics
- Class Anti-infectives; Antiallergics; Antiasthmatics; Bronchodilators; Catecholamines; Ethanolamines; Skin disorder therapies; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Beta-adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase III Anaphylaxis
Most Recent Events
- 14 Mar 2024 Aquestive Therapeutics plans a allergen PK study in Q2 2024
- 14 Mar 2024 Aquestive Therapeutics plans a pediatric PK study in Q3 2024
- 14 Mar 2024 Aquestive Therapeutics plans a slef-administration PK study in Q2 2024